PRESS RELEASES More events are coming soon. Keyword Search Year: 202120202019201820172016201520142013 03/23/21 Summary ToggleTRACON Pharmaceuticals Announces Poster Presentation at the 2021 AACR Virtual Annual Meeting Printer Friendly PDF Version 03/09/21 Summary ToggleTRACON Pharmaceuticals to Present at the Oppenheimer 31st Annual Healthcare Conference Printer Friendly PDF Version 03/08/21 Summary ToggleTRACON Pharmaceuticals Announces Appointment of Lisa Johnson-Pratt, M.D., to its Board of Directors Printer Friendly PDF Version 03/02/21 Summary ToggleTRACON Pharmaceuticals to Present at the H.C. Wainwright Global Life Sciences Conference Printer Friendly PDF Version 02/25/21 Summary ToggleTRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update Printer Friendly PDF Version 02/18/21 Summary ToggleTRACON to Report Fourth Quarter and Full Year 2020 Financial Results and Company Highlights on February 25, 2021 Printer Friendly PDF Version 01/19/21 Summary ToggleTRACON Pharmaceuticals Announces Acceptance of the Envafolimab (KN035) NDA by the NMPA in China for Priority Review Printer Friendly PDF Version 01/06/21 Summary ToggleTRACON Pharmaceuticals to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference Printer Friendly PDF Version 12/30/20 Summary ToggleTRACON Pharmaceuticals Announces Acceptance of the Envafolimab (KN035) NDA by the NMPA in China that was Submitted by its Corporate Partners Alphamab Oncology and 3D Medicines Printer Friendly PDF Version 12/29/20 Summary ToggleTRACON Pharmaceuticals Announces $5.0 Million Registered Direct Offering Printer Friendly PDF Version Pagination Current page 1 Page 2 Page 3 Page 4 … Next page Next Last page Last
